These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31411121)

  • 1. DMBT1 suppresses progression of gallbladder carcinoma through PI3K/AKT signaling pathway by targeting PTEN.
    Sheng S; Jiwen W; Dexiang Z; Bohao Z; Yueqi W; Han L; Xiaoling N; Tao S; Liu H
    Biosci Biotechnol Biochem; 2019 Dec; 83(12):2257-2264. PubMed ID: 31411121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway.
    Shen S; Liu H; Wang Y; Wang J; Ni X; Ai Z; Pan H; Liu H; Shao Y
    Oncotarget; 2016 Nov; 7(45):72833-72844. PubMed ID: 27637083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway.
    Ma N; Zhao Y
    Cell Biochem Funct; 2020 Aug; 38(6):801-809. PubMed ID: 32424818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer.
    Wei D; Rui B; Qingquan F; Chen C; Ping HY; Xiaoling S; Hao W; Jun G
    Int J Biol Sci; 2021; 17(2):514-526. PubMed ID: 33613109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
    Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oroxylin A Exerts Its Antitumor Effects in Human Gallbladder Cancer via Inhibition of the PTEN/PI3K/AKT Signaling Pathway.
    Xuan L; Zhang J; Ji J; Hu J; Li F
    Biol Pharm Bull; 2020; 43(10):1511-1518. PubMed ID: 32999161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.
    Zhang Y; Du P; Li Y; Zhu Q; Song X; Liu S; Hao J; Liu L; Liu F; Hu Y; Jiang L; Ma Q; Lu W; Liu Y
    Int J Biol Sci; 2020; 16(5):739-751. PubMed ID: 32071545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.
    Jin YP; Hu YP; Wu XS; Wu YS; Ye YY; Li HF; Liu YC; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu XY; Liu YB
    Cell Death Dis; 2018 Feb; 9(2):182. PubMed ID: 29416013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of aberrant PI3K pathway activation in gallbladder tumorigenesis.
    Lunardi A; Webster KA; Papa A; Padmani B; Clohessy JG; Bronson RT; Pandolfi PP
    Oncotarget; 2014 Feb; 5(4):894-900. PubMed ID: 24658595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma.
    Hu YP; Wu ZB; Jiang L; Jin YP; Li HF; Zhang YJ; Ma Q; Ye YY; Wang Z; Liu YC; Chen HZ; Liu YB
    Int J Biochem Cell Biol; 2018 Apr; 97():16-27. PubMed ID: 29413947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
    Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
    Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dioscin Induces Gallbladder Cancer Apoptosis by Inhibiting ROS-Mediated PI3K/AKT Signalling.
    Song X; Wang Z; Liang H; Zhang W; Ye Y; Li H; Hu Y; Zhang Y; Weng H; Lu J; Wang X; Li M; Liu Y; Gu J
    Int J Biol Sci; 2017; 13(6):782-793. PubMed ID: 28656003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
    Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
    Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C; Zhang B; Li YL; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA HOTAIR Promotes Endometrial Carcinoma Cell Proliferation by Binding to PTEN via the Activating Phosphatidylinositol 3-Kinase/Akt Signaling Pathway.
    Zhang XH; Hu P; Xie YQ; Kang YJ; Li M
    Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31527078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.
    Yao H; Su S; Xia D; Wang M; Li Z; Chen W; Ren L; Xu L
    Biomed Pharmacother; 2018 Nov; 107():1712-1719. PubMed ID: 30257389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.